ACU
ACME UNITED CORP
$45.55
+0.15%
$173.6M
No data for this timeframe.
Vol
Market Cap$173.6M
Cap SizeMicro Cap
Inst. Holders30 funds
Inst. Value$45.0M
Inst. Activity0 buys / 1 sells
Insider Activity0B / 1S
Insider Net $-$203.0K
SEC Reports3
Press Releases1
Recent Activity
May 28, 2026
Insider
OLSCHAN BRIAN S sold 4,833 shares
President and COO @ $42.00 ($203.0K)
May 27, 2026
Insider
JOHNSEN WALTER C gifted 5,834 shares
Chairman and CEO @ $42.23 ($246.4K)
May 21, 2026
Insider
OLSCHAN BRIAN S acquired via exercise 20,000 shares
President and COO @ $24.92 ($498.4K)
Apr 23, 2026
SEC
Acme United reported Q1 2026 earnings of $0.24 per diluted share on revenue of $52.3 million, missing consensus EPS of $
8-K — Impact 7/10
Apr 23, 2026
SEC
Acme United (ACU) reported Q1 2026 revenue of $52.3M, up 14% YoY, but EPS of $0.24 missed consensus by 40% due to higher
PRESS-RELEASE — Impact 7/10
Mar 11, 2026
Event
Savannah Antibacterial Towelettes (Benzalkonium Chloride 0.13%), 1 towelette, 4 x 7, R&R Enterprise, NDC 59647-749-02
Class II: CGMP Deviations
Feb 26, 2026
SEC
Acme United Corporation reported a 3% increase in Q4 revenue to $47.5 million and a 12% increase in diluted EPS to $0.46
8-K — Impact 7/10
Inst.
MORGAN STANLEY — TRIM
6,486 shares ($291.3K)
Price Targets
Historical data — last covering-analyst action Jul 2016. No current recommendation available.
$53.00 (Jul 2016)
Current $45.55
Low $53.00
Median $53.00
High $53.00
1 analysts
$53.00
$53.00
Analyst Ratings
2Strong Buy
2Buy
2Hold
0Sell
0Strong Sell
Historical Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Jul 1, 2016 | DA Davidson | INITIATE | Buy |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $0.40 ▼ -16.7% | $0.40 — $0.40 | -66% YoY | 1 |
| Next Q | $0.39 ▼ -9.3% | $0.39 — $0.39 | -15% YoY | 1 |
| Current FY | $1.41 ▼ -18.0% | $1.41 — $1.41 | -43% YoY | 1 |
| Next FY | $1.63 ▼ -9.9% | $1.63 — $1.63 | 16% YoY | 1 |
Latest Reports
BEARISH
8-K
7/10
Acme United reported Q1 2026 earnings of $0.24 per diluted share on revenue of $52.3 million, missing consensus EPS of $
Apr 23, 2026
BEARISH
PRESS-RELEASE
7/10
Acme United (ACU) reported Q1 2026 revenue of $52.3M, up 14% YoY, but EPS of $0.24 missed consensus by 40% due to higher
Apr 23, 2026
NEUTRAL
Press
3/10
Acme United Corporation (ACU) declared a cash dividend of $0.16 per share, payable on April 15, 2026, to shareholders of
Mar 12, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| DIMENSIONAL FUND ADVISORS LP | $7.7M | — |
| BlackRock, Inc. | $7.4M | — |
| ROYCE & ASSOCIATES LP | $6.6M | ADD |
| VANGUARD CAPITAL MANAGEMENT LLC | $6.3M | — |
| RENAISSANCE TECHNOLOGIES LLC | $5.2M | — |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| May 28, 2026 | OLSCHAN BRIAN | SELL | $203.0K |
| May 27, 2026 | JOHNSEN WALTER | G | $246.4K |
| May 21, 2026 | OLSCHAN BRIAN | M | $498.4K |
| May 21, 2026 | OLSCHAN BRIAN | F | $657.0K |
| May 13, 2026 | JOHNSEN WALTER | M | $719.7K |
30 institutional holders with $45.0M total value (1,002,170 shares) as of 2026-Q1. Top holders: DIMENSIONAL, BlackRock,, ROYCE. Net selling activity: 1 institutions trimmed/exited vs 0 added.
Top Institutional Holders — 2026-Q1
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | DIMENSIONAL FUND ADVISORS LP | 171,577 | $7.7M | 17.1% | — |
| 2 | BlackRock, Inc. | 165,690 | $7.4M | 16.5% | — |
| 3 | ROYCE & ASSOCIATES LP | 146,403 | $6.6M | 14.6% | ADD +25.0% |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | 140,992 | $6.3M | 14.1% | — |
| 5 | RENAISSANCE TECHNOLOGIES LLC | 116,558 | $5.2M | 11.6% | — |
| 6 | STATE STREET CORP | 42,257 | $1.9M | 4.2% | DOUBLED +157.7% |
| 7 | BROWN BROTHERS HARRIMAN & CO | 33,370 | $1.5M | 3.3% | — |
| 8 | ENVESTNET ASSET MANAGEMENT INC | 30,959 | $1.4M | 3.1% | TRIM -28.5% |
| 9 | VANGUARD FIDUCIARY TRUST CO | 21,041 | $945.0K | 2.1% | — |
| 10 | GOLDMAN SACHS GROUP INC | 20,244 | $909.2K | 2.0% | — |
| 11 | VANGUARD PORTFOLIO MANAGEMENT LLC | 19,369 | $869.9K | 1.9% | — |
| 12 | ROYAL BANK OF CANADA | 19,257 | $865.0K | 1.9% | — |
| 13 | DIAMOND HILL CAPITAL MANAGEMENT INC | 18,914 | $849.4K | 1.9% | ADD +39.7% |
| 14 | O'SHAUGHNESSY ASSET MANAGEMENT, LLC | 18,164 | $815.7K | 1.8% | TRIM -28.8% |
| 15 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 8,608 | $386.6K | 0.9% | — |
| 16 | CITADEL ADVISORS LLC | 6,952 | $312.2K | 0.7% | — |
| 17 | MORGAN STANLEY | 6,486 | $291.3K | 0.6% | TRIM -29.4% |
| 18 | &PARTNERS | 4,614 | $207.2K | 0.5% | — |
| 19 | RHUMBLINE ADVISERS | 2,415 | $108.5K | 0.2% | TRIM -25.1% |
| 20 | Vanguard Global Advisers, LLC | 1,758 | $79.0K | 0.2% | — |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| MORGAN STANLEY | TRIM | 9,184 | 6,486 | -29.4% | $291.3K | 2026-Q1 |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | TRIM | 25,242 | 17,984 | -28.8% | $724.9K | 2025-Q4 |
| MORGAN STANLEY | ADD | 6,766 | 9,184 | +35.7% | $370.2K | 2025-Q4 |
| WELLS FARGO & COMPANY/MN | ADD | 2,547 | 3,770 | +48.0% | $152.0K | 2025-Q4 |
| BANK OF AMERICA CORP /DE/ | ADD | 1,328 | 2,623 | +97.5% | $105.7K | 2025-Q4 |
| RHUMBLINE ADVISERS | TRIM | 3,172 | 2,377 | -25.1% | $95.8K | 2025-Q4 |
| LOS ANGELES CAPITAL MANAGEMENT LLC | TRIM | 5,339 | 2,274 | -57.4% | $87.1K | 2025-Q4 |
| Allworth Financial LP | TRIM | 3 | 1 | -66.7% | $41.00 | 2025-Q4 |
| CWM, LLC | TRIM | 82 | 40 | -51.2% | $2.00 | 2025-Q4 |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | ADD | 19,669 | 25,242 | +28.3% | $1.0M | 2025-Q3 |
| UBS Group AG | DOUBLED | 9,058 | 18,897 | +108.6% | $778.2K | 2025-Q3 |
| LOS ANGELES CAPITAL MANAGEMENT LLC | TRIM | 15,140 | 5,339 | -64.7% | $219.9K | 2025-Q3 |
| VANGUARD GROUP INC | ADD | 143,444 | 181,462 | +26.5% | $7.5M | 2025-Q2 |
| ENVESTNET ASSET MANAGEMENT INC | TRIM | 51,834 | 37,036 | -28.5% | $1.5M | 2025-Q2 |
| STATE STREET CORP | DOUBLED | 13,323 | 34,330 | +157.7% | $1.4M | 2025-Q2 |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | DOUBLED | 7,552 | 19,669 | +160.4% | $815.3K | 2025-Q2 |
| UBS Group AG | DOUBLED | 575 | 9,058 | +1475.3% | $375.5K | 2025-Q2 |
| BARCLAYS PLC | DOUBLED | 1,892 | 6,134 | +224.2% | $254.00 | 2025-Q2 |
| DIAMOND HILL CAPITAL MANAGEMENT INC | ADD | 14,006 | 19,569 | +39.7% | $775.1K | 2025-Q1 |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | TRIM | 16,615 | 7,552 | -54.5% | $299.1K | 2025-Q1 |
| MORGAN STANLEY | ADD | 4,725 | 6,555 | +38.7% | $259.6K | 2025-Q1 |
| CITIGROUP INC | TRIM | 5,141 | 3,213 | -37.5% | $127.3K | 2025-Q1 |
| UBS Group AG | ADD | 387 | 575 | +48.6% | $22.8K | 2025-Q1 |
| ROYCE & ASSOCIATES LP | ADD | 135,712 | 169,664 | +25.0% | $6.3M | 2024-Q4 |
| CITIGROUP INC | TRIM | 7,961 | 5,141 | -35.4% | $191.9K | 2024-Q4 |
4 unique insiders with 13 transactions. Net insider value: -$203.0K ($0.00 bought, $203.0K sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| May 28, 2026 | OLSCHAN BRIAN S | President and COO | SELL | 4,833 | $42.00 | $203.0K |
| May 27, 2026 | JOHNSEN WALTER C | Chairman and CEO | GIFT | 5,834 | $42.23 | $246.4K |
| May 21, 2026 | OLSCHAN BRIAN S | President and COO | EXERCISE | 20,000 | $24.92 | $498.4K |
| May 21, 2026 | OLSCHAN BRIAN S | President and COO | TAX W/H | 15,204 | $43.21 | $657.0K |
| May 13, 2026 | JOHNSEN WALTER C | Chairman and CEO | EXERCISE | 30,000 | $23.99 | $719.7K |
| May 13, 2026 | JOHNSEN WALTER C | Chairman and CEO | TAX W/H | 24,166 | $40.53 | $979.4K |
| Mar 3, 2026 | MURPHY SUSAN H | Director | GIFT | 1,200 | $44.08 | $52.9K |
| Mar 2, 2026 | DRISCOLL PAUL G | Chief Financial Officer | AWARD | 15,000 | $44.77 | $671.5K |
| Mar 2, 2026 | JOHNSEN WALTER C | Chairman and CEO | AWARD | 25,000 | $44.77 | $1.1M |
| Mar 2, 2026 | OLSCHAN BRIAN S | President and COO | AWARD | 20,000 | $44.77 | $895.4K |
| Feb 27, 2026 | JOHNSEN WALTER C | Chairman and CEO | EXERCISE | 30,000 | $21.49 | $644.7K |
| Feb 27, 2026 | DRISCOLL PAUL G | Chief Financial Officer | EXERCISE | 15,000 | $21.49 | $322.4K |
| Feb 27, 2026 | OLSCHAN BRIAN S | President and COO | EXERCISE | 15,000 | $24.92 | $373.8K |
3 SEC filing reports analyzed. Sentiment: 1 bullish, 2 bearish, 0 mixed, 0 neutral. Avg impact: 7.0/10.
BEARISH
8-K
7/10
Acme United reported Q1 2026 earnings of $0.24 per diluted share on revenue of $52.3 million, missin
Apr 23, 2026
BEARISH
PRESS-RELEASE
7/10
Acme United (ACU) reported Q1 2026 revenue of $52.3M, up 14% YoY, but EPS of $0.24 missed consensus
Apr 23, 2026
BULLISH
8-K
7/10
Acme United Corporation reported a 3% increase in Q4 revenue to $47.5 million and a 12% increase in
Feb 26, 2026
Historical analyst distribution (last covering-analyst action Jul 2016): 67% buy across 6 analysts — 2 strong buy, 2 buy, 2 hold, 0 sell, 0 strong sell. No current recommendation available.
Analyst Price Targets
Historical data — last covering-analyst action Jul 2016. No current recommendation available.
$53.00 mean target (Jul 2016)
$53.00 Low
$53.00 High
| Metric | Value |
|---|---|
| Current Price | $45.55 |
| Target Low | $53.00 |
| Target Mean | $53.00 |
| Target Median | $53.00 |
| Target High | $53.00 |
| # Analysts | 1 |
| Recommendation | — (no recent coverage) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$0.40 | $0.40 | $0.40 | -65.5% | -16.7% | 0↑ 1↓ | $0.1B | 3.3% | 1 |
| Next Q 2026-09-30 |
$0.39 | $0.39 | $0.39 | -15.2% | -9.3% | 0↑ 1↓ | $0.1B | 10.9% | 1 |
| Current FY 2026-12-31 |
$1.41 | $1.41 | $1.41 | -43.4% | -18.0% | 0↑ 1↓ | $0.2B | 9.4% | 1 |
| Next FY 2027-12-31 |
$1.63 | $1.63 | $1.63 | 15.6% | -9.9% | 0↑ 1↓ | $0.2B | 3.7% | 1 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $0.400 | |
| 7d ago | $0.480 | -0.080 |
| 30d ago | $0.480 | -0.080 |
| 60d ago | $0.470 | -0.070 |
| 90d ago | $0.470 | -0.070 |
1 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 1 initiations.
Historical Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Jul 1, 2016 | DA Davidson | INITIATE | — | Buy |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 2 | 2 | 2 | 0 | 0 | 67% | |
| May 1, 2026 | 2 | 3 | 1 | 0 | 0 | 83% | |
| Apr 1, 2026 | 2 | 3 | 1 | 0 | 0 | 83% | |
| Mar 1, 2026 | 2 | 3 | 1 | 0 | 0 | 83% | |
| Feb 1, 2026 | 2 | 3 | 1 | 0 | 0 | 83% | |
| Jan 1, 2026 | 2 | 3 | 1 | 0 | 0 | 83% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
Apr 23, 2026
earnings
Acme United Reports First Quarter 2026 Financial Results
<p align="left">SHELTON, Conn., April 23, 2026 (GLOBE NEWSWIRE) -- Acme United Corporation (NYSE American: ACU) today announced that net sales for t
Apr 23, 2026
earnings_calendar
ACU Q1 2026 Earnings Scheduled — 2026-04-23
Apr 17, 2026
earnings_calendar
ACU Q1 2026 Earnings Scheduled — 2026-04-17
Apr 15, 2026
earnings
Acme United to Release First Quarter 2026 Financial Results on April 23, 2026
<p>SHELTON, Conn., April 15, 2026 (GLOBE NEWSWIRE) -- Acme United Corporation (NYSE American: ACU) will release its financial results for the first
Mar 12, 2026
dividend
Acme United Corporation Board Approves Cash Dividend
<p align="justify">SHELTON, Conn., March 12, 2026 (GLOBE NEWSWIRE) -- The Board of Directors of Acme United Corporation (NYSE American: ACU) declare
Mar 11, 2026
FDA
Savannah Antibacterial Towelettes (Benzalkonium Chloride 0.13%), 1 towelette, 4 x 7, R&R Enterprise, NDC 59647-749-02
Class II: CGMP Deviations
Mar 11, 2026
FDA
BZK Antiseptic Towelettes (Benzalkonium Chloride 0.13%), 5" x7", 1000 ea Bulk, Med-Nap, Brooksville, FL 34601, Made in USA, NDC 0924-0246-02.
Class II: CGMP Deviations
Mar 11, 2026
FDA
Dynarex Obstetrical Towelettes Cleanser (Benzalkonium Chloride 0.13%), 100 packets, 5" x 7", Manufactured for Dynarex Corporation, 10 Glenshaw Street, Orangeburg, NY 10962, USA Made in USA, NDC 67777-244-02
Class II: CGMP Deviations
Mar 11, 2026
FDA
Dynarex, BZK Antiseptic Towelettes (Benzalkonium Chloride 0.13%), 100 packets, 5x7, Manufactured for Dynarex Corporation, 10 Glenshaw Street, Orangeburg, NY 10962,USA, NDC 67777-245-01
Class II: CGMP Deviations
Mar 11, 2026
FDA
Med-Nap Cleansing Towelettes (Benzalkonium Chloride 0.13%), 100 Towelettes, Manufactured by: Acme United Corporation, 1 Waterview Dr., Stelton, CT 06484, NDC 0924-0243-01.
Class II: CGMP Deviations
Feb 26, 2026
earnings_calendar
ACU Q4 2025 Earnings Scheduled — 2026-02-26